Fig. 6

Analysis of Riskscore and Immune Landscape. (A) Differential analysis revealed that the degree of immune infiltration, calculated using the ssGSEA algorithm, varied between patients in different risk groups. (B) Differential analysis found that the high-risk group had a higher StromalScore, ImmuneScore and ESTIMATEScore. (C) Differential analysis found that the MSI score was higher in the high-risk group. (D) MMR genes were found to be closely associated with riskscore. (E) Radar plots showed the correlation between riskscore and multiple immune checkpoints. (F) Differential analysis found that the high-risk group had a higher tumor TIDE score. (G, H) Patients with higher riskscore were more likely to experience remission according to the IMvigor210 dataset.